Latest filing published 21 May 2026 for FIREBRICK PHARMA LIMITED, €16k. Read the official filing
Only one filing by Peter Laurence Molloy Date of last notice 10 October 2024 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust is known so far (21 May 2026): an open-market purchase, €16k, in Firebrick Pharma Limited. That is too little to draw conclusions. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration